{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T07:55:19Z","timestamp":1781769319470,"version":"3.54.5"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"The Science and Technology Research Program of Henan Province","award":["242102310256"],"award-info":[{"award-number":["242102310256"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"DOI":"10.1007\/s00431-026-07011-4","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T22:38:02Z","timestamp":1778020682000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical features and therapeutic outcomes in pediatric patients with Castleman\u2019s disease: a retrospective cohort analysis"],"prefix":"10.1007","volume":"185","author":[{"given":"Yuanyuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixin","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru ting","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia Ning","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongcheng","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangkun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,6]]},"reference":[{"issue":"4","key":"7011_CR1","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1002\/1097-0142(195607\/08)9:4<822::aid-cncr2820090430>3.0.co;2-4","volume":"9","author":"B Castleman","year":"1956","unstructured":"Castleman B, Iverson L, Menendez VP (1956) Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer 9(4):822\u2013830. https:\/\/doi.org\/10.1002\/1097-0142(195607\/08)9:4<822::aid-cncr2820090430>3.0.co;2-4","journal-title":"Cancer"},{"issue":"10","key":"7011_CR2","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1002\/1097-0142(19851115)56:10<2446::aid-cncr2820561020>3.0.co;2-4","volume":"56","author":"E Kessler","year":"1985","unstructured":"Kessler E (1985) Multicentric giant lymph node hyperplasia. A report of seven cases. Cancer 56(10):2446\u20132451. https:\/\/doi.org\/10.1002\/1097-0142(19851115)56:10<2446::aid-cncr2820561020>3.0.co;2-4","journal-title":"Cancer"},{"issue":"4","key":"7011_CR3","doi-asserted-by":"publisher","first-page":"e163","DOI":"10.1016\/S2352-3026(16)00006-5","volume":"3","author":"AY Liu","year":"2016","unstructured":"Liu AY, Nabel CS, Finkelman BS et al (2016) Idiopathic multicentric Castleman\u2019s disease: a systematic literature review. Lancet Haematol 3(4):e163\u2013e175. https:\/\/doi.org\/10.1016\/S2352-3026(16)00006-5","journal-title":"Lancet Haematol"},{"issue":"6","key":"7011_CR4","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/modpathol.2013.202","volume":"27","author":"KC Chang","year":"2014","unstructured":"Chang KC, Wang YC, Hung LY et al (2014) Monoclonality and cytogenetic abnormalities in hyaline vascular Castleman disease. Mod Pathol 27(6):823\u2013831. https:\/\/doi.org\/10.1038\/modpathol.2013.202","journal-title":"Mod Pathol"},{"issue":"4","key":"7011_CR5","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1097\/SLA.0b013e318249dcdc","volume":"255","author":"N Talat","year":"2012","unstructured":"Talat N, Belgaumkar AP, Schulte KM (2012) Surgery in Castleman\u2019s disease: a systematic review of 404 published cases. Ann Surg 255(4):677\u2013684. https:\/\/doi.org\/10.1097\/SLA.0b013e318249dcdc","journal-title":"Ann Surg"},{"issue":"12","key":"7011_CR6","doi-asserted-by":"publisher","first-page":"5519","DOI":"10.1007\/s00431-023-05235-2","volume":"182","author":"S Hu","year":"2023","unstructured":"Hu S, Li Z, Wang H et al (2023) Clinical features and treatment outcomes of Castleman disease in children: a retrospective cohort in China. Eur J Pediatr 182(12):5519\u20135530. https:\/\/doi.org\/10.1007\/s00431-023-05235-2","journal-title":"Eur J Pediatr"},{"issue":"5","key":"7011_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27613","volume":"66","author":"J Sopfe","year":"2019","unstructured":"Sopfe J, Endres A, Campbell K et al (2019) Castleman disease in pediatrics: insights on presentation, treatment, and outcomes from a two-site retrospective cohort study. Pediatr Blood Cancer 66(5):e27613. https:\/\/doi.org\/10.1002\/pbc.27613","journal-title":"Pediatr Blood Cancer"},{"issue":"12","key":"7011_CR8","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1182\/blood-2016-10-746933","volume":"129","author":"DC Fajgenbaum","year":"2017","unstructured":"Fajgenbaum DC, Uldrick TS, Bagg A et al (2017) International, evidence-based consensus diagnostic criteria for HHV-8-negative\/idiopathic multicentric Castleman disease. Blood 129(12):1646\u20131657. https:\/\/doi.org\/10.1182\/blood-2016-10-746933","journal-title":"Blood"},{"issue":"6","key":"7011_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0218660","volume":"14","author":"CS Nabel","year":"2019","unstructured":"Nabel CS, Sameroff S, Shilling D et al (2019) Virome capture sequencing does not identify active viral infection in unicentric and idiopathic multicentric Castleman disease. PLoS One 14(6):e0218660. https:\/\/doi.org\/10.1371\/journal.pone.0218660","journal-title":"PLoS One"},{"issue":"11","key":"7011_CR10","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1159\/000526640","volume":"45","author":"C Hoffmann","year":"2022","unstructured":"Hoffmann C, Hentrich M, Tiemann M et al (2022) Recent advances in Castleman disease. Oncol Res Treat 45(11):693\u2013704. https:\/\/doi.org\/10.1159\/000526640","journal-title":"Oncol Res Treat"},{"issue":"1","key":"7011_CR11","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/s41572-021-00317-7","volume":"7","author":"A Carbone","year":"2021","unstructured":"Carbone A, Borok M, Damania B et al (2021) Castleman disease. Nat Rev Dis Primers 7(1):84. https:\/\/doi.org\/10.1038\/s41572-021-00317-7","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"7011_CR12","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/bjh.15019","volume":"180","author":"E Oksenhendler","year":"2018","unstructured":"Oksenhendler E, Boutboul D, Fajgenbaum D et al (2018) The full spectrum of Castleman disease: 273 patients studied over 20 years. Br J Haematol 180(2):206\u2013216. https:\/\/doi.org\/10.1111\/bjh.15019","journal-title":"Br J Haematol"},{"issue":"3","key":"7011_CR13","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1002\/1097-0142(20010801)92:3<670::aid-cncr1369>3.0.co;2-q","volume":"92","author":"GM Chronowski","year":"2001","unstructured":"Chronowski GM, Ha CS, Wilder RB, Cabanillas F, Manning J, Cox JD (2001) Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy. Cancer 92(3):670\u2013676. https:\/\/doi.org\/10.1002\/1097-0142(20010801)92:3<670::aid-cncr1369>3.0.co;2-q","journal-title":"Cancer"},{"issue":"23","key":"7011_CR14","doi-asserted-by":"publisher","first-page":"6039","DOI":"10.1182\/bloodadvances.2020003334","volume":"4","author":"F van Rhee","year":"2020","unstructured":"van Rhee F, Oksenhendler E, Srkalovic G et al (2020) International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease. Blood Adv 4(23):6039\u20136050. https:\/\/doi.org\/10.1182\/bloodadvances.2020003334","journal-title":"Blood Adv"},{"issue":"1","key":"7011_CR15","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.hoc.2017.09.004","volume":"32","author":"D Wu","year":"2018","unstructured":"Wu D, Lim MS, Jaffe ES (2018) Pathology of Castleman disease. Hematol Oncol Clin North Am 32(1):37\u201352. https:\/\/doi.org\/10.1016\/j.hoc.2017.09.004","journal-title":"Hematol Oncol Clin North Am"},{"issue":"1","key":"7011_CR16","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1053\/j.semdp.2017.11.014","volume":"35","author":"MA Piris","year":"2018","unstructured":"Piris MA, Aguirregoicoa E, Montes-Moreno S, Celeiro-Mu\u00f1oz C (2018) Castleman disease and Rosai-Dorfman disease. Semin Diagn Pathol 35(1):44\u201353. https:\/\/doi.org\/10.1053\/j.semdp.2017.11.014","journal-title":"Semin Diagn Pathol"},{"issue":"4","key":"7011_CR17","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1038\/s41375-018-0323-6","volume":"33","author":"Z Li","year":"2019","unstructured":"Li Z, Lan X, Li C et al (2019) Recurrent PDGFRB mutations in unicentric Castleman disease. Leukemia 33(4):1035\u20131038. https:\/\/doi.org\/10.1038\/s41375-018-0323-6","journal-title":"Leukemia"},{"issue":"2","key":"7011_CR18","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/bjh.15921","volume":"186","author":"D Boutboul","year":"2019","unstructured":"Boutboul D, Fadlallah J, Chawki S et al (2019) Treatment and outcome of unicentric Castleman disease: a retrospective analysis of 71 cases. Br J Haematol 186(2):269\u2013273. https:\/\/doi.org\/10.1111\/bjh.15921","journal-title":"Br J Haematol"},{"issue":"22","key":"7011_CR19","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1182\/blood-2018-05-848671","volume":"132","author":"DC Fajgenbaum","year":"2018","unstructured":"Fajgenbaum DC (2018) Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease. Blood 132(22):2323\u20132330. https:\/\/doi.org\/10.1182\/blood-2018-05-848671","journal-title":"Blood"},{"issue":"11","key":"7011_CR20","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1002\/ajh.23291","volume":"87","author":"A Dispenzieri","year":"2012","unstructured":"Dispenzieri A, Armitage JO, Loe MJ et al (2012) The clinical spectrum of Castleman\u2019s disease. Am J Hematol 87(11):997\u20131002. https:\/\/doi.org\/10.1002\/ajh.23291","journal-title":"Am J Hematol"},{"issue":"6","key":"7011_CR21","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1148\/rg.316115502","volume":"31","author":"D Bonekamp","year":"2011","unstructured":"Bonekamp D, Horton KM, Hruban RH, Fishman EK (2011) Castleman disease: the great mimic. Radiographics 31(6):1793\u20131807. https:\/\/doi.org\/10.1148\/rg.316115502","journal-title":"Radiographics"},{"issue":"8","key":"7011_CR22","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1182\/blood-2004-12-4602","volume":"106","author":"N Nishimoto","year":"2005","unstructured":"Nishimoto N, Kanakura Y, Aozasa K et al (2005) Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease. Blood 106(8):2627\u20132632. https:\/\/doi.org\/10.1182\/blood-2004-12-4602","journal-title":"Blood"},{"issue":"11","key":"7011_CR23","doi-asserted-by":"publisher","first-page":"771","DOI":"10.2169\/internalmedicine","volume":"46","author":"M Matsuyama","year":"2007","unstructured":"Matsuyama M, Suzuki T, Tsuboi H et al (2007) Anti-interleukin-6 receptor antibody (tocilizumab) treatment of multicentric Castleman\u2019s disease. Intern Med 46(11):771\u2013774. https:\/\/doi.org\/10.2169\/internalmedicine","journal-title":"Intern Med"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-07011-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-026-07011-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-07011-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T07:33:40Z","timestamp":1781768020000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-026-07011-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,6]]},"references-count":23,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["7011"],"URL":"https:\/\/doi.org\/10.1007\/s00431-026-07011-4","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,6]]},"assertion":[{"value":"25 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the guiding principles of the Declaration of Helsinki, and the study protocol was approved by the Ethics Committee of the First Affiliated Hospital of Zhengzhou University. Informed consent was waived due to the retrospective nature of enrollment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read and approved the final manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors affirm that no artificial intelligence tools were utilized during the writing process.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"The role of generative artificial intelligence in scientific writing"}}],"article-number":"350"}}